2327. Deputy Ken O'Flynn asked the Minister for Health whether any review, analysis, assessment, briefing, report, business case, internal examination or other evaluation has been undertaken since 1 January 2024 regarding the drivers of variation in reimbursement costs for salbutamol nebule products under the General Medical Services Scheme; if so, to provide the date, author, purpose and principal findings of each such review; and if no such review has been undertaken, to confirm that fact. [43627/26]

Summary

2327. Deputy Ken O'Flynn asked the Minister for Health whether any review, analysis, assessment, briefing, report, business case, internal examination or other evaluation has been undertaken since 1 January 2024 regarding the drivers of variation in reimbursement costs for salbutamol nebule products under the General Medical Services Scheme; if so, to provide the date, author, purpose and principal findings of each such review; and if no such review has been undertaken, to confirm that fact. [43627/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 9 June 2026

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.